These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37886708)

  • 1. Comparing Jaffe and Enzymatic Methods for Creatinine Measurement at Various Icterus Levels and Their Impacts on Liver Transplant Allocation.
    Soleimani N; Dehghani S; Anbardar MH; Mohammadzadeh S; Amirinezhad Fard E; Zare Sheibani A; Esmaeili MJ; Ebrahimi M
    Int J Anal Chem; 2023; 2023():9804533. PubMed ID: 37886708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of different creatinine measurement methods on liver transplant allocation.
    Kaiser T; Kinny-Köster B; Bartels M; Parthaune T; Schmidt M; Thiery J
    PLoS One; 2014; 9(2):e90015. PubMed ID: 24587188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When results matter: reliable creatinine concentrations in hyperbilirubinemia patients.
    Roelofsen-de Beer RJAC; van Zelst BD; Vroling AB; de Rijke YB; Ramakers C
    Clin Chem Lab Med; 2019 Apr; 57(5):659-667. PubMed ID: 30496132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Center-related Bias in MELD Scores Within a Liver Transplant UNOS Region: A Call for Standardization.
    Verna EC; Connelly C; Dove LM; Adem P; Babic N; Corsetti J; Faix J; Hayden JA; Lifshitz M; Stotler B; Jin Z; Mohan S; Emond JC; Hod EA; Kratz A
    Transplantation; 2020 Jul; 104(7):1396-1402. PubMed ID: 31651793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited comparability of creatinine assays in patients with liver cirrhosis and their impact on the MELD score.
    Kaiser T; Kinny-Köster B; Gnewuch C; Karailieva D; Kiehntopf M; Kessler A; Ritter-Sket C; Schmidt M; Brand K; Thiery J; Lichtinghagen R
    Pract Lab Med; 2017 Aug; 8():41-48. PubMed ID: 28856226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolving icteric interference by a novel photoisomerization device: Bilibox.
    Vera MA; Koch CD; El-Khoury JM
    Clin Biochem; 2023 May; 115():112-115. PubMed ID: 35882276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different methods of creatinine measurement significantly affect MELD scores.
    Cholongitas E; Marelli L; Kerry A; Senzolo M; Goodier DW; Nair D; Thomas M; Patch D; Burroughs AK
    Liver Transpl; 2007 Apr; 13(4):523-9. PubMed ID: 17323365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Analytical Impact of Moving from Jaffe to Enzymatic Serum Creatinine Methodology.
    Syme NR; Stevens K; Stirling C; McMillan DC; Talwar D
    J Appl Lab Med; 2020 Jul; 5(4):631-642. PubMed ID: 32447368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reevaluating the Icterus Index Cutoff of a Jaffé Creatinine Method.
    Alvarez YF; Kelliher MT; Hubbard JA; Nerenz RD; Cervinski MA
    J Appl Lab Med; 2022 Sep; 7(5):1151-1157. PubMed ID: 35899580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Inter-Laboratory Variability on Model of End-Stage Liver Disease (MELD) Score Calculation.
    Al-Saeedi M; Yassein T; Schultze D; Nickkholgh A; Bruns H; Zorn M; Hinz U; Ganten TM; Schemmer P
    Ann Transplant; 2016 Nov; 21():675-682. PubMed ID: 27799654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interlaboratory variability in assessment of the model of end-stage liver disease score.
    Lisman T; van Leeuwen Y; Adelmeijer J; Pereboom IT; Haagsma EB; van den Berg AP; Porte RJ
    Liver Int; 2008 Dec; 28(10):1344-51. PubMed ID: 18482269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between ADVIA Chemistry systems Enzymatic Creatinine_2 method and ADVIA Chemistry systems Creatinine method (kinetic Jaffe method) for determining creatinine.
    Hermida FJ; Lorenzo MJ; Pérez A; Fernández M; Sagastagoia O; Magadán C
    Scand J Clin Lab Invest; 2014 Oct; 74(7):629-36. PubMed ID: 24988313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of laboratory-induced MELD score differences on liver allocation: more reality than myth.
    Schouten JN; Francque S; Van Vlierberghe H; Colle I; Nevens F; Delwaide J; Adler M; Starkel P; Ysebaert D; Gadisseur A; De Winter B; Smits JM; Rahmel A; Michielsen P
    Clin Transplant; 2012; 26(1):E62-70. PubMed ID: 22032173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of reproducibility of creatinine measurement and MELD scoring in four liver transplant units in the UK.
    Goulding C; Cholongitas E; Nair D; Kerry A; Patch D; Akyol M; Walker S; Manas D; Mc Clure D; Smith L; Jamieson N; Oberg I; Cartwright D; Burroughs AK
    Nephrol Dial Transplant; 2010 Mar; 25(3):960-6. PubMed ID: 19892752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of bilirubin interference and accuracy of six creatinine assays compared with isotope dilution-liquid chromatography mass spectrometry.
    Nah H; Lee SG; Lee KS; Won JH; Kim HO; Kim JH
    Clin Biochem; 2016 Feb; 49(3):274-81. PubMed ID: 26519089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Data on the frequency and causes of icteric interference in clinical chemistry laboratory tests.
    Merrill AE; Mainali S; Krasowski MD
    Data Brief; 2022 Feb; 40():107771. PubMed ID: 35036480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-weighting the model for end-stage liver disease score components.
    Sharma P; Schaubel DE; Sima CS; Merion RM; Lok AS
    Gastroenterology; 2008 Nov; 135(5):1575-81. PubMed ID: 18835388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum ultrafiltration for the elimination of endogenous interfering substances in creatinine determination.
    da Fonseca-Wollheim F; Heinze KG; Lomsky K; Schreiner H
    J Clin Chem Clin Biochem; 1988 Aug; 26(8):523-5. PubMed ID: 3221182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prime time for enzymatic creatinine methods in pediatrics.
    Cobbaert CM; Baadenhuijsen H; Weykamp CW
    Clin Chem; 2009 Mar; 55(3):549-58. PubMed ID: 19168555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The international normalized ratio of prothrombin time in the model for end-stage liver disease score: a reliable measure.
    Kamath PS; Kim WR
    Clin Liver Dis; 2009 Feb; 13(1):63-66. PubMed ID: 19150310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.